Table 2 Circulating microRNA expressions in different cancer cell/tumor
From: MicroRNA’s in cancer as biomarkers and therapeutic keys
| S. NO. | miRNA | Cancer | Role | Author |
|---|---|---|---|---|
| 1 | mir-375 | Low in OSCC patient plasma | Sensitive to Radiotherapy | [112] |
| 2 | mir-125b | Low in OSCC patient plasma | Proliferation inhibition and migration | [113] |
| 3 | mir-196 | Over expressed in Head and neck squamous cell carcinoma (HNSCC) | Resistance to Radiotherapy | [114] |
| 4 | miR-150 | Low expression in Esophageal Squamous Cell Carcinoma | Involved in tumor malignancy – metastasis in lymphnode, lymph invasion and low prognosis level | [115] |
| 5 | mir-21 | Over expression in Tongue Sqamous Cell Carcinoma | Late stage marker and metastasis in Lymph node | [116] |
| 6 | mir-134 | HNSCC | Metastasis | [117] |
| 7 | mir-146a | High Concentration in OSCC | Increase in metastasis and Tumorogensis | [118] |